Square Pharmaceuticals' Director Anjan Chowdhury yesterday expressed his intention to buy 15 lakh shares of his company, the largest drug producer in Bangladesh.
A congenial business environment is yet to be restored under the interim government, said Tapan Chowdhury, managing director of Square Pharmaceuticals.
Square Pharmaceuticals PLC registered a 9 percent year-on-year growth in profit to Tk 600 crore in July-September this year.
Square Pharmaceuticals Ltd clocked a Tk 1,491.01 crore profit in the July-March period of the ongoing financial year, up 4.9 per cent from a year earlier.
Drug maker Renata Ltd has secured approval from the US Food and Drug Administration (USFDA) for its general facility in Rajendrapur.
Square Pharmaceuticals Kenya EPZ Ltd, a subsidiary of Square Pharmaceuticals, has recently received a go-ahead to start commercial manufacturing in its Kenyan factory.
The company will manufacture and sell generic pharmaceutical medicine in Kenya and East African Community (EAC).
Square Pharmaceuticals' Director Anjan Chowdhury yesterday expressed his intention to buy 15 lakh shares of his company, the largest drug producer in Bangladesh.
A congenial business environment is yet to be restored under the interim government, said Tapan Chowdhury, managing director of Square Pharmaceuticals.
Square Pharmaceuticals PLC registered a 9 percent year-on-year growth in profit to Tk 600 crore in July-September this year.
Square Pharmaceuticals Ltd clocked a Tk 1,491.01 crore profit in the July-March period of the ongoing financial year, up 4.9 per cent from a year earlier.
Drug maker Renata Ltd has secured approval from the US Food and Drug Administration (USFDA) for its general facility in Rajendrapur.
Square Pharmaceuticals Kenya EPZ Ltd, a subsidiary of Square Pharmaceuticals, has recently received a go-ahead to start commercial manufacturing in its Kenyan factory.
The company will manufacture and sell generic pharmaceutical medicine in Kenya and East African Community (EAC).
